Veillonella seminalis

Information

Microbe Identification

Veillonella seminalis

Microbe id: PMDBM2021727
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Veillonella seminalis [1502943]
Taxonomy Genus: Veillonella [29465]
Taxonomy Family: Veillonellaceae [31977]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Veillonella seminalis

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Veillonella seminalis


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Veillonella seminalis distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Veillonella seminalis in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Veillonella seminalis

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJEB65297🔗3.25114707533984mNGS
Diabetes Mellitus, Type 2 PRJNA719138🔗-4.1037319499047616S
Liver Cirrhosis, Alcoholic PRJNA690835🔗4.506176031338916S
Diarrhea PRJNA317326🔗4.397014037273416S
Dwarfism PRJNA819198🔗3.4581338534412916S
Colorectal Neoplasms PRJNA1126038🔗-3.0162136030599116S
Colorectal Neoplasms PRJEB46665🔗-2.2817342804846716S
Colorectal Neoplasms PRJNA1167935🔗3.77250714092577mNGS
Colorectal Neoplasms PRJEB70916🔗4.15608998613453mNGS
Colorectal Neoplasms PRJNA986175🔗4.1621936557514716S
Colorectal Neoplasms PRJNA824020🔗4.4320428700980516S
Respiratory Syncytial Virus Infections PRJNA579491🔗-4.6363886260801416S
Lupus Erythematosus, Systemic PRJEB55711🔗3.23961530522337mNGS
Hepatitis, Autoimmune PRJNA556801🔗4.7249571639057516S
Colitis, Ulcerative PRJNA993675🔗3.57344445890357mNGS
Colitis, Ulcerative PRJNA917086🔗4.2315773322967116S
Campylobacter Infections PRJNA660443🔗4.15784150067791mNGS
Spinal Cord Injuries PRJNA861246🔗2.7591070404613516S
Hepatitis B, Chronic PRJNA872871🔗3.9149361347150416S
Carcinoma, Hepatocellular PRJNA872871🔗4.3429671848066416S
Celiac Disease PRJNA890948🔗4.170625148859916S
Helicobacter Infections PRJDB10599🔗-3.674691030091416S
Caliciviridae Infections PRJNA788674🔗4.8156823095760616S
Prostatic Neoplasms PRJNA769284🔗3.58529682104761mNGS
Schizophrenia PRJNA1135717🔗3.6331645022807mNGS
Crohn Disease PRJNA398089🔗2.74416745451026mNGS
Crohn Disease PRJNA793776🔗3.92625454376194mNGS
Crohn Disease PRJNA993675🔗4.02406326308812mNGS
Crohn Disease PRJEB42155🔗4.17431630346034mNGS
Crohn Disease PRJEB6172🔗4.8084616367576616S
Mastitis PRJNA667141🔗-3.8585086859075516S
Schistosomiasis haematobia PRJNA526732🔗2.8214509051981916S
Purpura, Thrombocytopenic, Idiopathic PRJNA858062🔗3.20367223902459mNGS
Purpura, Thrombocytopenic, Idiopathic PRJNA531564🔗3.7967806648141516S
Moyamoya Disease PRJNA917033🔗-3.6880227819026916S
Diabetic Retinopathy PRJNA857030🔗-3.4074077708395716S
Dermatitis, Atopic PRJEB45443🔗4.27070128058134mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗2.84882611460177mNGS
Fatigue Syndrome, Chronic PRJNA379741🔗2.95700793654253mNGS
Cholangiocarcinoma PRJNA932948🔗4.51635801837979mNGS
Hepatitis C PRJNA328966🔗4.1518315833068316S
Neuroblastoma PRJEB63351🔗4.02575942011076mNGS
Hematologic Neoplasms PRJNA777832🔗4.217069205047116S
Myasthenia Gravis PRJNA450610🔗4.6480498679969116S
Depressive Disorder, Major PRJNA762199🔗-3.43466875723104mNGS
Lung Neoplasms PRJNA736821🔗-4.0406666027343316S
Liver Diseases, Alcoholic PRJNA540738🔗4.6841027612420216S
Liver Cirrhosis PRJNA861246🔗2.7973844235460616S
Cystic Fibrosis PRJNA314903🔗4.9941378411949mNGS
Enterocolitis, Necrotizing PRJNA889687🔗-4.7099148650289216S
HIV Infections PRJNA810567🔗4.3304617645710616S
Inflammatory Bowel Diseases PRJNA511372🔗4.00060815192428mNGS
Inflammatory Bowel Diseases PRJNA993675🔗4.09469061918255mNGS
Inflammatory Bowel Diseases PRJNA1028828🔗4.0978939741309516S
Hand, Foot and Mouth Disease PRJNA1017976🔗4.3515255358593416S
Renal Insufficiency, Chronic PRJEB65297🔗3.44992682159432mNGS
Renal Insufficiency, Chronic PRJNA562327🔗3.7504092157950316S
Amebiasis PRJNA608066🔗4.987364664106816S
COVID-19 PRJNA678695🔗-3.937867788374316S
COVID-19 PRJNA769052🔗-3.1597683438807116S
Sepsis PRJNA641414🔗4.3863699893061216S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Veillonella seminalis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Veillonella seminalis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Veillonella seminalis

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Veillonella seminalis


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Veillonella seminalis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Veillonella seminalis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Veillonella seminalis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Veillonella seminalis

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Veillonella seminalis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Veillonella seminalis


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Veillonella seminalis


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?